PLUR Pluri Inc.

Pluri Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Shemesh-Rasmussen Maital was granted 11,173 shares, increasing direct ownership by 154% to 18,445 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:19 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Director Levi Rami Avraham was granted 11,173 shares, increasing direct ownership by 156% to 18,314 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:22 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Chief Financial Officer Zalts Liat was granted 67,857 shares, increasing direct ownership by 319% to 89,107 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:17 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Director Manieu Alexandre Weinstein was granted 10,250 shares (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:07 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Director Aberman Zami was granted 14,350 shares, increasing direct ownership by 11% to 143,866 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:08 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Chief Executive Officer Yanay Yaky was granted 181,900 shares, increasing direct ownership by 67% to 452,120 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:07 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Director Birger Pinhas Doron was granted 11,685 shares, increasing direct ownership by 156% to 19,178 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
2/27/25 4:00:05 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
New insider Manieu Alexandre Weinstein claimed ownership of 1,383,948 shares (SEC Form 3)
3 - Pluri Inc. (0001158780) (Issuer)
2/18/25 8:28:19 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
New insider Zalts Liat claimed ownership of 21,250 shares (SEC Form 3)
3 - Pluri Inc. (0001158780) (Issuer)
9/30/24 4:00:14 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Chief Executive Officer Yanay Yaky was granted 25,240 shares, increasing direct ownership by 8% to 332,756 units (SEC Form 4)
4 - Pluri Inc. (0001158780) (Issuer)
9/20/24 4:00:07 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care

Pluri Inc. SEC Filings

SEC Form DEF 14A filed by Pluri Inc.
DEF 14A - Pluri Inc. (0001158780) (Filer)
5/27/25 4:00:57 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Pluri Inc. filed SEC Form 8-K: Other Events
8-K - Pluri Inc. (0001158780) (Filer)
5/27/25 8:30:13 AM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form 10-Q filed by Pluri Inc.
10-Q - Pluri Inc. (0001158780) (Filer)
5/13/25 4:03:23 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Pluri Inc. filed SEC Form 8-K: Other Events
8-K - Pluri Inc. (0001158780) (Filer)
5/8/25 8:30:07 AM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Pluri Inc. filed SEC Form 8-K: Shareholder Director Nominations
8-K - Pluri Inc. (0001158780) (Filer)
4/29/25 4:00:31 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form PRE 14A filed by Pluri Inc.
PRE 14A - Pluri Inc. (0001158780) (Filer)
4/28/25 9:08:02 AM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Pluri Inc. filed SEC Form 8-K: Other Events
8-K - Pluri Inc. (0001158780) (Filer)
4/28/25 8:05:26 AM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Pluri Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Pluri Inc. (0001158780) (Filer)
4/25/25 5:18:52 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Pluri Inc. filed SEC Form 8-K: Other Events
8-K - Pluri Inc. (0001158780) (Filer)
4/17/25 4:01:26 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form D filed by Pluri Inc.
D - Pluri Inc. (0001158780) (Filer)
3/19/25 4:10:09 PM ET
$PLUR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care

Pluri Inc.

Recent Analyst Ratings for Pluri Inc.

Pluri Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Shemesh-Rasmussen Maital was granted 11,173 shares, increasing direct ownership by 154% to 18,445 units (SEC Form 4)

Director Levi Rami Avraham was granted 11,173 shares, increasing direct ownership by 156% to 18,314 units (SEC Form 4)

Chief Financial Officer Zalts Liat was granted 67,857 shares, increasing direct ownership by 319% to 89,107 units (SEC Form 4)

Director Manieu Alexandre Weinstein was granted 10,250 shares (SEC Form 4)

Director Aberman Zami was granted 14,350 shares, increasing direct ownership by 11% to 143,866 units (SEC Form 4)

Chief Executive Officer Yanay Yaky was granted 181,900 shares, increasing direct ownership by 67% to 452,120 units (SEC Form 4)

Director Birger Pinhas Doron was granted 11,685 shares, increasing direct ownership by 156% to 19,178 units (SEC Form 4)

New insider Manieu Alexandre Weinstein claimed ownership of 1,383,948 shares (SEC Form 3)

New insider Zalts Liat claimed ownership of 21,250 shares (SEC Form 3)

Chief Executive Officer Yanay Yaky was granted 25,240 shares, increasing direct ownership by 8% to 332,756 units (SEC Form 4)

Pluri Inc. SEC Filings

SEC Form DEF 14A filed by Pluri Inc.

Pluri Inc. filed SEC Form 8-K: Other Events

SEC Form 10-Q filed by Pluri Inc.

Pluri Inc. filed SEC Form 8-K: Other Events

Pluri Inc. filed SEC Form 8-K: Shareholder Director Nominations

SEC Form PRE 14A filed by Pluri Inc.

Pluri Inc. filed SEC Form 8-K: Other Events

Pluri Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

Pluri Inc. filed SEC Form 8-K: Other Events

SEC Form D filed by Pluri Inc.